IN2014MU00193A - - Google Patents

Info

Publication number
IN2014MU00193A
IN2014MU00193A IN193MU2014A IN2014MU00193A IN 2014MU00193 A IN2014MU00193 A IN 2014MU00193A IN 193MU2014 A IN193MU2014 A IN 193MU2014A IN 2014MU00193 A IN2014MU00193 A IN 2014MU00193A
Authority
IN
India
Prior art keywords
acceptable derivative
pharmaceutical
doripenem
ertapenem
meropenem
Prior art date
Application number
Inventor
Mahesh Vithalbhai Patel
Sachin Bhagwat
Jaykumar Satwaji Satav
Hemant Narendra Khande
Prashant Ratnakar Joshi
Snehal Rameshwar Palwe
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU2017110457A priority Critical patent/RU2705375C2/en
Priority to BR112017003444A priority patent/BR112017003444A2/en
Priority to AU2015208830A priority patent/AU2015208830A1/en
Priority to US15/323,631 priority patent/US10322116B2/en
Priority to CA2954553A priority patent/CA2954553C/en
Priority to IN193MU2014 priority patent/IN2014MU00193A/en
Priority to ES15708275T priority patent/ES2804500T3/en
Priority to EP15708275.1A priority patent/EP3217979B8/en
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to NZ728036A priority patent/NZ728036A/en
Priority to PCT/IB2015/050421 priority patent/WO2015110950A1/en
Publication of IN2014MU00193A publication Critical patent/IN2014MU00193A/en
Priority to ZA2017/00064A priority patent/ZA201700064B/en
Priority to US15/846,929 priority patent/US20180104224A1/en
Priority to AU2020201956A priority patent/AU2020201956B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

A pharmaceutical compositions comprising: (a) a carbapenem antibacterial agent selected from imipenem, meropenem, ertapenem, doripenem or a pharmaceutically acceptable derivative thereof, and (b) a compound of Formula (I), or a stereoisomer or a pharmaceutical acceptable derivative thereof, are disclosed.
IN193MU2014 2014-01-21 2015-01-20 IN2014MU00193A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ES15708275T ES2804500T3 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
AU2015208830A AU2015208830A1 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
US15/323,631 US10322116B2 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
CA2954553A CA2954553C (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
IN193MU2014 IN2014MU00193A (en) 2014-01-21 2015-01-20
RU2017110457A RU2705375C2 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions containing antibacterial agents
EP15708275.1A EP3217979B8 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
BR112017003444A BR112017003444A2 (en) 2014-01-21 2015-01-20 PHARMACEUTICAL COMPOSITIONS, AND USES OF ANTIBACTERIAL AGENTS
NZ728036A NZ728036A (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
PCT/IB2015/050421 WO2015110950A1 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
ZA2017/00064A ZA201700064B (en) 2014-01-21 2017-01-04 Pharmaceutical compositions comprising antibacterial agents
US15/846,929 US20180104224A1 (en) 2014-01-21 2017-12-19 Pharmaceutical compositions comprising antibacterial agents
AU2020201956A AU2020201956B2 (en) 2014-01-21 2020-03-18 Pharmaceutical compositions comprising antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN193MU2014 IN2014MU00193A (en) 2014-01-21 2015-01-20

Publications (1)

Publication Number Publication Date
IN2014MU00193A true IN2014MU00193A (en) 2015-08-28

Family

ID=52629621

Family Applications (1)

Application Number Title Priority Date Filing Date
IN193MU2014 IN2014MU00193A (en) 2014-01-21 2015-01-20

Country Status (11)

Country Link
US (2) US10322116B2 (en)
EP (1) EP3217979B8 (en)
AU (2) AU2015208830A1 (en)
BR (1) BR112017003444A2 (en)
CA (1) CA2954553C (en)
ES (1) ES2804500T3 (en)
IN (1) IN2014MU00193A (en)
NZ (1) NZ728036A (en)
RU (1) RU2705375C2 (en)
WO (1) WO2015110950A1 (en)
ZA (1) ZA201700064B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
DK2748165T3 (en) 2011-08-27 2016-12-19 Wockhardt Ltd 1,6-diazabicyclo [3,2,1] octane-7-ON DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
AU2013268415B2 (en) * 2012-05-30 2017-05-25 Meiji Seika Pharma Co., Ltd. Novel beta-lactamase inhibitor and method for producing same
CN104884092A (en) * 2013-01-14 2015-09-02 沃克哈特有限公司 Compositions and methods for treating bacterial infections
RU2509560C1 (en) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" New therapeutic combinations of mirtazapine applicable in pain conditions

Also Published As

Publication number Publication date
NZ728036A (en) 2019-12-20
AU2020201956A1 (en) 2020-04-02
EP3217979A1 (en) 2017-09-20
AU2015208830A1 (en) 2017-04-27
BR112017003444A2 (en) 2023-03-07
WO2015110950A1 (en) 2015-07-30
CA2954553C (en) 2022-12-06
US20170202813A1 (en) 2017-07-20
RU2017110457A3 (en) 2018-10-03
CA2954553A1 (en) 2015-07-30
EP3217979B8 (en) 2020-06-03
ZA201700064B (en) 2018-08-29
US10322116B2 (en) 2019-06-18
US20180104224A1 (en) 2018-04-19
RU2017110457A (en) 2018-10-03
RU2705375C2 (en) 2019-11-07
EP3217979B1 (en) 2020-04-08
ES2804500T3 (en) 2021-02-08
AU2020201956B2 (en) 2020-07-09

Similar Documents

Publication Publication Date Title
EP3687543A4 (en) Combination pharmaceutical agents as rsv inhibitors
GEP20207074B (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
MD20160118A2 (en) Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
EP3253382A4 (en) Pharmaceutical compositions for combination therapy
EP3280421A4 (en) Pharmaceutical compositions for combination therapy
MX2016013431A (en) Pharmaceutical compositions comprising antibacterial agents.
EP3417853A4 (en) Pharmaceutical composition for treatment of cancer, containing polyphenol compound as active ingredient
MX2018014813A (en) Antibacterial compositions.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
EP3946316A4 (en) Cannabidiol pharmaceutical compositions
EP3682016A4 (en) Formulations for compound delivery
MX2016005160A (en) Pharmaceutical compositions comprising antibacterial agents.
MX2016005539A (en) Pharmaceutical compositions comprising antibacterial agents.
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents
IN2014MU00859A (en)
IN2013MU03421A (en)
IN2014MU00193A (en)
EP3984549A4 (en) Medicinal composition
EP3914234A4 (en) Pharmaceutical compositions
EP3949952A4 (en) Medicinal composition
MX2016013428A (en) Pharmaceutical compositions comprising antibacterial agents.
EP3650024A4 (en) Pharmaceutical composition for nasal administration
MX2017010992A (en) Stable pharmaceutical compositions comprising antibacterial agent.
MX2016012646A (en) Pharmaceutical compositions comprising cefepime or sulbactam.